JP2017533263A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017533263A5 JP2017533263A5 JP2017540961A JP2017540961A JP2017533263A5 JP 2017533263 A5 JP2017533263 A5 JP 2017533263A5 JP 2017540961 A JP2017540961 A JP 2017540961A JP 2017540961 A JP2017540961 A JP 2017540961A JP 2017533263 A5 JP2017533263 A5 JP 2017533263A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- diyl
- substituted
- independently
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 24
- 125000000217 alkyl group Chemical group 0.000 claims 17
- -1 piperazine-1,4-diyl Chemical group 0.000 claims 13
- 125000001424 substituent group Chemical group 0.000 claims 12
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 7
- 229910052760 oxygen Inorganic materials 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- 125000003107 substituted aryl group Chemical group 0.000 claims 5
- 208000023275 Autoimmune disease Diseases 0.000 claims 4
- 208000035473 Communicable disease Diseases 0.000 claims 4
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 4
- 125000003282 alkyl amino group Chemical group 0.000 claims 4
- 208000037976 chronic inflammation Diseases 0.000 claims 4
- 208000037893 chronic inflammatory disorder Diseases 0.000 claims 4
- 229910052717 sulfur Inorganic materials 0.000 claims 4
- 125000003118 aryl group Chemical group 0.000 claims 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N diethylenediamine Natural products C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 claims 3
- 125000001475 halogen functional group Chemical group 0.000 claims 3
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 3
- 241001120493 Arene Species 0.000 claims 2
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 241001465754 Metazoa Species 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims 2
- 206010012601 diabetes mellitus Diseases 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 150000002148 esters Chemical class 0.000 claims 2
- 208000015181 infectious disease Diseases 0.000 claims 2
- 206010022000 influenza Diseases 0.000 claims 2
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000004103 aminoalkyl group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 125000005885 heterocycloalkylalkyl group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462068322P | 2014-10-24 | 2014-10-24 | |
| US62/068,322 | 2014-10-24 | ||
| US201562101164P | 2015-01-08 | 2015-01-08 | |
| US62/101,164 | 2015-01-08 | ||
| PCT/US2015/021417 WO2016064445A1 (en) | 2014-10-24 | 2015-03-19 | Lanthionine synthetase c-like 2-based therapeutics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019046867A Division JP6806829B2 (ja) | 2014-10-24 | 2019-03-14 | ランチオニンシンテターゼｃ様２系治療薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017533263A JP2017533263A (ja) | 2017-11-09 |
| JP2017533263A5 true JP2017533263A5 (enExample) | 2018-04-26 |
| JP6499306B2 JP6499306B2 (ja) | 2019-04-10 |
Family
ID=52811239
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017540961A Active JP6499306B2 (ja) | 2014-10-24 | 2015-03-19 | ランチオニンシンテターゼｃ様２系治療薬 |
| JP2019046867A Active JP6806829B2 (ja) | 2014-10-24 | 2019-03-14 | ランチオニンシンテターゼｃ様２系治療薬 |
| JP2020201503A Pending JP2021073170A (ja) | 2014-10-24 | 2020-12-04 | ランチオニンシンテターゼｃ様２系治療薬 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019046867A Active JP6806829B2 (ja) | 2014-10-24 | 2019-03-14 | ランチオニンシンテターゼｃ様２系治療薬 |
| JP2020201503A Pending JP2021073170A (ja) | 2014-10-24 | 2020-12-04 | ランチオニンシンテターゼｃ様２系治療薬 |
Country Status (21)
| Country | Link |
|---|---|
| US (9) | US9556146B2 (enExample) |
| EP (2) | EP3757099B1 (enExample) |
| JP (3) | JP6499306B2 (enExample) |
| KR (3) | KR102026342B1 (enExample) |
| CN (2) | CN107108573B (enExample) |
| AU (3) | AU2015337091B2 (enExample) |
| BR (1) | BR112017008416B1 (enExample) |
| CA (1) | CA2965472C (enExample) |
| DK (1) | DK3209655T3 (enExample) |
| ES (1) | ES2822987T3 (enExample) |
| HR (1) | HRP20201416T1 (enExample) |
| HU (1) | HUE051299T2 (enExample) |
| IL (2) | IL252630B (enExample) |
| LT (1) | LT3209655T (enExample) |
| NZ (1) | NZ732213A (enExample) |
| PL (1) | PL3209655T3 (enExample) |
| PT (1) | PT3209655T (enExample) |
| RS (1) | RS61013B1 (enExample) |
| RU (3) | RU2741576C2 (enExample) |
| SI (1) | SI3209655T1 (enExample) |
| WO (1) | WO2016064445A1 (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3209655T (pt) | 2014-10-24 | 2020-11-13 | Landos Biopharma Inc | Produtos terapêuticos à base da lancl2 |
| US11529354B2 (en) | 2017-09-05 | 2022-12-20 | President And Fellows Of Harvard College | Methods and compositions for the treatment of tuberculosis |
| WO2019099426A1 (en) * | 2017-11-17 | 2019-05-23 | Icahn School Of Medicine At Mount Sinai | Influenza virus inhibitor targeting nucleoprotein |
| AU2018374767A1 (en) | 2017-11-30 | 2020-06-25 | Landos Biopharma, Inc. | Therapies with lanthionine C-like protein 2 ligands and cells prepared therewith |
| TW202039481A (zh) | 2018-12-21 | 2020-11-01 | 美商西建公司 | Ripk2之噻吩并吡啶抑制劑 |
| MX2022001915A (es) * | 2019-12-20 | 2022-03-17 | Landos Biopharma Inc | Ligandos de proteina 2 tipo lantionina c, celulas preparadas con los mismos y terapias que usan los mismos. |
| US12234578B2 (en) | 2020-01-29 | 2025-02-25 | Wisconsin Alumni Research Foundation | Tannin composite fibers |
| WO2021174024A1 (en) | 2020-02-28 | 2021-09-02 | First Wave Bio, Inc. | Methods of treating iatrogenic autoimmune colitis |
| WO2022057932A1 (zh) * | 2020-09-18 | 2022-03-24 | 上海医药集团股份有限公司 | 一种羰基杂环类化合物及其应用 |
| CN114195780A (zh) * | 2020-09-18 | 2022-03-18 | 上海医药集团股份有限公司 | 一种羰基杂环类化合物及其应用 |
| WO2022087146A1 (en) * | 2020-10-22 | 2022-04-28 | Landos Biopharma, Inc. | Lancl ligands |
| US11492342B2 (en) | 2020-11-03 | 2022-11-08 | Landos Biopharma, Inc. | Crystalline forms of piperazine-1,4-diylbis((6-(1H-benzo[d]imidazo-2-yl)pyridin-2yl)methanone) |
| WO2022108997A2 (en) * | 2020-11-19 | 2022-05-27 | Landos Biopharma, Inc. | Compounds, compositions, and methods for treating inflammatory or immune-mediated conditions of surface tissues |
| CN116670137B (zh) * | 2020-12-15 | 2025-06-06 | 康百达（四川）生物医药科技有限公司 | 吡啶衍生物及其在医药上的应用 |
| CN113908256B (zh) * | 2021-11-26 | 2023-05-26 | 中国农业科学院兰州兽医研究所 | Lancl1蛋白在制备抗病毒药物中的应用 |
| WO2024155555A1 (en) * | 2023-01-16 | 2024-07-25 | Nimml Institute | Neuroprotective compounds for therapeutic use |
Family Cites Families (63)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0282643A3 (en) | 1986-11-22 | 1990-08-22 | The Green Cross Corporation | Use of pharmaceutical compositions comprising cyclohexane derivatives in the treatment or prevention of peptic ulcers |
| AU708349B2 (en) * | 1994-12-23 | 1999-08-05 | Smithkline Beecham Corporation | 4,4-(disubstituted)cyclohexan-1-one monomers and related compounds |
| IL117580A0 (en) | 1995-03-29 | 1996-07-23 | Merck & Co Inc | Inhibitors of farnesyl-protein transferase and pharmaceutical compositions containing them |
| US5856326A (en) | 1995-03-29 | 1999-01-05 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
| US5633388A (en) | 1996-03-29 | 1997-05-27 | Viropharma Incorporated | Compounds, compositions and methods for treatment of hepatitis C |
| DE69738907D1 (de) * | 1996-10-11 | 2008-09-25 | Kowa Co | Neue diamidverbindungen und medikamente die diese enthalten |
| JP4627881B2 (ja) * | 1997-12-24 | 2011-02-09 | ３−ブイ・バイオサイエンシーズ・インコーポレイテッド | 骨粗鬆症の治療に有用なａ．ｏ．インドール誘導体 |
| EP1052992A1 (en) | 1998-02-02 | 2000-11-22 | Merck & Co., Inc. | Cyclic amine modulators of chemokine receptor activity |
| GB9914825D0 (en) * | 1999-06-24 | 1999-08-25 | Smithkline Beecham Spa | Novel compounds |
| JP2001247550A (ja) * | 1999-12-27 | 2001-09-11 | Japan Tobacco Inc | 縮合環化合物及びその医薬用途 |
| WO2001064666A1 (en) * | 2000-03-02 | 2001-09-07 | Kyowa Hakko Kogyo Co., Ltd. | Oxygen-containing heterocyclic compounds |
| US20090124690A1 (en) | 2000-04-03 | 2009-05-14 | Alberte Randall S | Generation of Combinatorial Synthetic Libraries and Screening for Novel Proadhesins and Nonadhesins |
| RU2297413C2 (ru) | 2000-09-15 | 2007-04-20 | Анормед, Инк. | Гетероциклические соединения, моделирующие активность хемокинового рецептора, их применение и содержащая их фармацевтическая композиция |
| EP1752455B1 (en) | 2000-09-15 | 2010-11-10 | Anormed Inc. | Chemokine receptor binding heterocyclic compounds |
| SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
| GB0112834D0 (en) | 2001-05-25 | 2001-07-18 | Smithkline Beecham Plc | Medicaments |
| TW200406413A (en) | 2002-06-26 | 2004-05-01 | Glaxo Group Ltd | Compounds |
| JPWO2005037269A1 (ja) | 2003-10-21 | 2006-12-28 | 住友製薬株式会社 | 新規ピペリジン誘導体 |
| WO2005082905A1 (ja) * | 2004-02-26 | 2005-09-09 | Kyowa Hakko Kogyo Co., Ltd. | 二環性複素環化合物 |
| US7674907B2 (en) | 2004-07-23 | 2010-03-09 | Amgen Inc. | Furanopyridine derivatives and methods of use |
| WO2006052844A2 (en) | 2004-11-04 | 2006-05-18 | Medical College Of Georgia Research Institute | Tolerogenic vaccine and method |
| US7919487B2 (en) | 2004-11-10 | 2011-04-05 | Synta Pharmaceuticals Corporation | Heteroaryl compounds |
| WO2006080821A1 (en) | 2005-01-28 | 2006-08-03 | Daewoong Pharmaceutical Co., Ltd. | Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| GB0508314D0 (en) * | 2005-04-25 | 2005-06-01 | Novartis Ag | Organic compounds |
| CN100434419C (zh) | 2005-06-03 | 2008-11-19 | 中国人民解放军军事医学科学院毒物药物研究所 | 单环多取代饱和环已酮类化合物及其制备方法和用途 |
| US7754724B2 (en) | 2005-06-30 | 2010-07-13 | Dow Agrosciences Llc | N-substituted piperazines |
| WO2007010965A1 (ja) | 2005-07-22 | 2007-01-25 | Shionogi & Co., Ltd. | Ｐｇｄ２受容体アンタゴニスト活性を有するアザインドール酸誘導体 |
| JP5072594B2 (ja) | 2005-07-22 | 2012-11-14 | 塩野義製薬株式会社 | Ｐｇｄ２受容体アンタゴニスト活性を有するインドール誘導体 |
| DK1910384T3 (da) | 2005-08-04 | 2012-12-17 | Sirtris Pharmaceuticals Inc | Imidazo [2,1-b] thiazol-derivater som sirtuinmodulerende forbindelser |
| US8143285B2 (en) | 2005-09-06 | 2012-03-27 | Shionogi & Co., Ltd. | Indolecarboxylic acid derivative having PGD2 receptor antagonistic activity |
| EP2407453A1 (en) | 2005-09-27 | 2012-01-18 | Shionogi & Co., Ltd. | PGD2 receptor antagonist |
| AR055669A1 (es) | 2005-10-03 | 2007-08-29 | Astrazeneca Ab | Derivados de 3h - imidazo[4, 5 -b]piridina como inhibidores selectivos de gsk3, metodos e internediarios para su preparacion, composiciones farmaceuticas que los contienen y su uso para la elaboracion de un medicamento para el tratamiento de enfermedades neurodegenerativas y mentales. |
| US20070203236A1 (en) | 2006-01-11 | 2007-08-30 | Smith Jeffrey W | Novel antagonists of the human fatty acid synthase thioesterase |
| US7741367B2 (en) | 2006-02-08 | 2010-06-22 | Virginia Tech Intellectual Properties, Inc. | Method of using abscisic acid to treat diseases and disorders |
| US8367727B2 (en) | 2006-02-08 | 2013-02-05 | Virginia Tech Intellectual Properties, Inc. | Method of using abscisic acid to treat diseases and disorders |
| JP2008056615A (ja) | 2006-08-31 | 2008-03-13 | Fujifilm Corp | ビニルエチニルアリールカルボン酸類、その製造方法及びそれを用いた熱架橋性化合物の製造方法 |
| WO2008061373A1 (en) | 2006-11-24 | 2008-05-29 | Waratah Pharmaceuticals Inc. | Combination treatments for alzheimer's disease and similar diseases |
| WO2008079277A1 (en) | 2006-12-22 | 2008-07-03 | Millennium Pharmaceuticals, Inc. | Certain pyrazoline derivatives with kinase inhibitory activity |
| WO2008092006A2 (en) | 2007-01-24 | 2008-07-31 | Cernofina, Llc | Antimicrobial compositions |
| MY146643A (en) | 2007-07-30 | 2012-09-14 | Dae Woong Pharma | Novel benzoimidazole derivatives and pharmaceutical composition comprising the same |
| WO2009067600A2 (en) | 2007-11-21 | 2009-05-28 | Decode Genetics Ehf | Biaryl pde4 inhibitors for treating inflammation |
| JP2011504505A (ja) | 2007-11-21 | 2011-02-10 | デコード ジェネティクス イーエイチエフ | 肺および心血管障害を治療するためのビアリールｐｄｅ４抑制剤 |
| JP5478499B2 (ja) | 2008-10-27 | 2014-04-23 | 田辺三菱製薬株式会社 | 新規アミド誘導体およびその医薬としての用途 |
| RU2505540C2 (ru) | 2008-12-23 | 2014-01-27 | Эббви Инк. | Антивирусные соединения |
| CA2647900C (en) | 2008-12-23 | 2017-05-16 | National Research Council Of Canada | Inhibitors of a 9-cis-epoxycarotenoid dioxygenase |
| SG172353A1 (en) | 2008-12-23 | 2011-07-28 | Abbott Lab | Anti-viral compounds |
| MX2011010964A (es) | 2009-04-17 | 2011-11-02 | Janssen Pharmaceutica Nv | Antagonistas del receptor 2 de citocina quimioatrayente de 4- azetidinil-1-fenil-ciclohexano. |
| US9062564B2 (en) * | 2009-07-31 | 2015-06-23 | General Electric Company | Solvent based slurry compositions for making environmental barrier coatings and environmental barrier coatings comprising the same |
| EP2488486B1 (en) * | 2009-10-13 | 2019-08-14 | Ligand Pharmaceuticals Inc. | Hematopoietic growth factor mimetic small molecule compounds and their uses |
| DE102009057167A1 (de) | 2009-12-05 | 2011-06-09 | Merck Patent Gmbh | Elektronische Vorrichtung enthaltend Metallkomplexe |
| JP2011246461A (ja) | 2010-04-27 | 2011-12-08 | Mitsubishi Tanabe Pharma Corp | 新規アミド誘導体を含有する医薬組成物 |
| EP2567225B1 (en) * | 2010-05-04 | 2019-10-02 | Virginia Tech Intellectual Properties, Inc. | Lanthionine synthetase component c-like proteins as molecular targets for preventing and treating diseases and disorders |
| WO2011150160A2 (en) | 2010-05-26 | 2011-12-01 | Virginia Tech Intellectual Properties, Inc. | Method of preventing and treating inflammatory diseases and disorders with abscisic acid |
| TW201211027A (en) | 2010-06-09 | 2012-03-16 | Janssen Pharmaceutica Nv | Cyclohexyl-azetidinyl antagonists of CCR2 |
| US8518969B2 (en) | 2010-06-17 | 2013-08-27 | Janssen Pharmaceutica Nv | Cyclohexyl-azetidinyl antagonists of CCR2 |
| SG186850A1 (en) | 2010-07-29 | 2013-02-28 | Rigel Pharmaceuticals Inc | Ampk-activating heterocyclic compounds and methods for using the same |
| KR20120035285A (ko) | 2010-10-05 | 2012-04-16 | 에스케이이노베이션 주식회사 | 셀룰로오스아세테이트 필름 |
| CA2861939A1 (en) | 2011-12-30 | 2013-07-04 | Centaurus Biopharma Co., Ltd. | Novel arylalkene derivatives and use thereof as selective estrogen receptor modulators |
| CN103709115A (zh) | 2012-10-09 | 2014-04-09 | 山东亨利医药科技有限责任公司 | 截短侧耳素类抗生素衍生物 |
| WO2014164299A1 (en) | 2013-03-13 | 2014-10-09 | Inflammatory Response Research, Inc. | Use of levocetirizine and montelukast in the treatment of autoimmune disorders |
| US20150087673A1 (en) | 2013-09-26 | 2015-03-26 | Rigel Pharmaceuticals, Inc. | Methods for using and biomarkers for ampk-activating compounds |
| JP6150701B2 (ja) | 2013-09-30 | 2017-06-21 | キヤノン株式会社 | 電子写真感光体、プロセスカートリッジおよび電子写真装置 |
| PT3209655T (pt) * | 2014-10-24 | 2020-11-13 | Landos Biopharma Inc | Produtos terapêuticos à base da lancl2 |
-
2015
- 2015-03-19 PT PT157143520T patent/PT3209655T/pt unknown
- 2015-03-19 RU RU2019110152A patent/RU2741576C2/ru active
- 2015-03-19 NZ NZ732213A patent/NZ732213A/en unknown
- 2015-03-19 BR BR112017008416-3A patent/BR112017008416B1/pt active IP Right Grant
- 2015-03-19 HU HUE15714352A patent/HUE051299T2/hu unknown
- 2015-03-19 RU RU2017117562A patent/RU2688677C2/ru active
- 2015-03-19 WO PCT/US2015/021417 patent/WO2016064445A1/en not_active Ceased
- 2015-03-19 SI SI201531382T patent/SI3209655T1/sl unknown
- 2015-03-19 ES ES15714352T patent/ES2822987T3/es active Active
- 2015-03-19 CN CN201580070262.8A patent/CN107108573B/zh active Active
- 2015-03-19 RS RS20201226A patent/RS61013B1/sr unknown
- 2015-03-19 LT LTEP15714352.0T patent/LT3209655T/lt unknown
- 2015-03-19 AU AU2015337091A patent/AU2015337091B2/en active Active
- 2015-03-19 KR KR1020177014045A patent/KR102026342B1/ko active Active
- 2015-03-19 CN CN202010405608.8A patent/CN111592508A/zh active Pending
- 2015-03-19 KR KR1020197027820A patent/KR102134171B1/ko active Active
- 2015-03-19 JP JP2017540961A patent/JP6499306B2/ja active Active
- 2015-03-19 US US14/662,506 patent/US9556146B2/en active Active
- 2015-03-19 EP EP20178083.0A patent/EP3757099B1/en active Active
- 2015-03-19 DK DK15714352.0T patent/DK3209655T3/da active
- 2015-03-19 PL PL15714352T patent/PL3209655T3/pl unknown
- 2015-03-19 HR HRP20201416TT patent/HRP20201416T1/hr unknown
- 2015-03-19 EP EP15714352.0A patent/EP3209655B1/en active Active
- 2015-03-19 KR KR1020207019853A patent/KR20200087273A/ko not_active Ceased
- 2015-03-19 CA CA2965472A patent/CA2965472C/en active Active
-
2016
- 2016-12-09 US US15/374,556 patent/US9839635B2/en active Active
-
2017
- 2017-06-01 IL IL252630A patent/IL252630B/en active IP Right Grant
- 2017-10-27 US US15/795,906 patent/US10028950B2/en active Active
-
2018
- 2018-06-13 US US16/007,151 patent/US10201538B2/en active Active
- 2018-12-20 US US16/227,940 patent/US10493072B2/en active Active
-
2019
- 2019-02-21 AU AU2019201231A patent/AU2019201231A1/en not_active Abandoned
- 2019-03-14 JP JP2019046867A patent/JP6806829B2/ja active Active
- 2019-10-15 US US16/653,446 patent/US10682349B2/en active Active
-
2020
- 2020-05-04 US US16/866,169 patent/US10849895B2/en active Active
- 2020-06-05 IL IL275155A patent/IL275155B/en active IP Right Grant
- 2020-10-15 RU RU2020133839A patent/RU2768888C1/ru active
- 2020-10-20 US US17/075,199 patent/US11571419B2/en active Active
- 2020-12-04 JP JP2020201503A patent/JP2021073170A/ja active Pending
-
2021
- 2021-03-04 AU AU2021201405A patent/AU2021201405B2/en active Active
-
2022
- 2022-12-20 US US18/085,018 patent/US12502388B2/en active Active